Correction: FGF1ΔHBS ameliorates chronic kidney disease via PI3K/AKT mediated suppression of oxidative stress and inflammation
Main Authors: | Dezhong Wang, Mengyun Jin, Xinyu Zhao, Tianyang Zhao, Wei Lin, Zhengle He, Miaojuan Fan, Wei Jin, Jie Zhou, Lingwei Jin, Chao Zheng, Hui Jin, Yushuo Zhao, Xiaokun Li, Lei Ying, Yang Wang, Guanghui Zhu, Zhifeng Huang |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2023-04-01
|
Series: | Cell Death and Disease |
Online Access: | https://doi.org/10.1038/s41419-023-05808-x |
Similar Items
-
FGF1ΔHBS prevents diabetic cardiomyopathy by maintaining mitochondrial homeostasis and reducing oxidative stress via AMPK/Nur77 suppression
by: Dezhong Wang, et al.
Published: (2021-03-01) -
FGF4, A New Potential Regulator in Gestational Diabetes Mellitus
by: Miaojuan Fan, et al.
Published: (2022-03-01) -
FGF10 Enhances Peripheral Nerve Regeneration via the Preactivation of the PI3K/Akt Signaling-Mediated Antioxidant Response
by: Lvpeng Dong, et al.
Published: (2019-10-01) -
Differential specificity of endocrine FGF19 and FGF21 to FGFR1 and FGFR4 in complex with KLB.
by: Chaofeng Yang, et al.
Published: (2012-01-01) -
Clinical and Virological Characteristics of Chronic Hepatitis B Patients with Coexistence of HBsAg and Anti-HBs.
by: Yong Liu, et al.
Published: (2016-01-01)